CYSLTR2 and neoplasm: Our integrative analysis of miRNA-mRNA expression data predicted new potential targets of miR-125b, namely RASGRF2 and CYSLTR2. Low expression of RASGRF2 has been described in lymphoma, lung cancer, cancer cell lines and primary tumour but not in MM (Chen et al. 2006).